that was out on the 16th so I don't think so, but out of that report was this ....... "The CDC in the US is expected to announce the Cellestis test as the preferred test"
I think we are about to get a positive kick from the CDC
I also noticed that cellestis has a sales force in the US of 8 where as Pharmaxis has 15 Europe Cellestis has 8 Pharmaxis has 25
I've got to wonder why we don't have more people out there selling, as we are a profitable company, where as Pharmaxis isn't, but when they get going I'm sure they will outstrip us within a very short space of time, Hmmm
CST Price at posting:
$3.63 Sentiment: Hold Disclosure: Held